These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 35521219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral dysbiosis and its linkage with SARS-CoV-2 infection.
    Gupta A, Bhanushali S, Sanap A, Shekatkar M, Kharat A, Raut C, Bhonde R, Shouche Y, Kheur S, Sharma A.
    Microbiol Res; 2022 Aug; 261():127055. PubMed ID: 35597076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A, Koga M, Mizutani T, Yamayoshi S, Iwatsuki-Horimoto K, Adachi E, Suzuki Y, Kawaoka Y, Yotsuyanagi H.
    BMC Microbiol; 2024 Jan 03; 24(1):6. PubMed ID: 38172680
    [Abstract] [Full Text] [Related]

  • 7. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    Yadav M, Ali S, Shrode RL, Shahi SK, Jensen SN, Hoang J, Cassidy S, Olalde H, Guseva N, Paullus M, Cherwin C, Wang K, Cho T, Kamholz J, Mangalam AK.
    PLoS One; 2022 Jan 03; 17(4):e0264556. PubMed ID: 35472144
    [Abstract] [Full Text] [Related]

  • 8. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
    Rizzello F, Viciani E, Gionchetti P, Filippone E, Imbesi V, Melotti L, Dussias NK, Salice M, Santacroce B, Padella A, Velichevskaya A, Marcante A, Castagnetti A.
    Front Cell Infect Microbiol; 2024 Jan 03; 14():1352202. PubMed ID: 38510960
    [Abstract] [Full Text] [Related]

  • 9. Transcriptome analysis reveals increased abundance and diversity of opportunistic fungal pathogens in nasopharyngeal tract of COVID-19 patients.
    Hoque MN, Rahman MS, Sarkar MMH, Habib MA, Akter S, Banu TA, Goswami B, Jahan I, Hossain MA, Khan MS, Islam T.
    PLoS One; 2023 Jan 03; 18(1):e0278134. PubMed ID: 36656835
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB.
    Front Immunol; 2021 Jan 03; 12():635471. PubMed ID: 33717181
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.
    Maeda Y, Motooka D, Kawasaki T, Oki H, Noda Y, Adachi Y, Niitsu T, Okamoto S, Tanaka K, Fukushima K, Amiya S, Hara R, Oguro-Igashira E, Matsuki T, Hirata H, Takeda Y, Kida H, Kumanogoh A, Nakamura S, Takeda K.
    BMC Infect Dis; 2022 Jun 24; 22(1):572. PubMed ID: 35751044
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diabetic foot exacerbates gut mycobiome dysbiosis in adult patients with type 2 diabetes mellitus: revealing diagnostic markers.
    Cai Y, Li Y, Xiong Y, Geng X, Kang Y, Yang Y.
    Nutr Diabetes; 2024 Sep 03; 14(1):71. PubMed ID: 39223127
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.